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Abstract
Soil-inhabiting streptomycetes are nature’s medicine makers, producing over half of all known antibiotics and many other
bioactive natural products. However, these bacteria also produce many volatiles, molecules that disperse through the soil
matrix and may impact other (micro)organisms from a distance. Here, we show that soil- and surface-grown streptomycetes
have the ability to kill bacteria over long distances via air-borne antibiosis. Our research shows that streptomycetes do so by
producing surprisingly high amounts of the low-cost volatile ammonia, dispersing over long distances to inhibit the growth
of Gram-positive and Gram-negative bacteria. Glycine is required as precursor to produce ammonia, and inactivation of the
glycine cleavage system nullified ammonia biosynthesis and concomitantly air-borne antibiosis. Reduced expression of
the porin master regulator OmpR and its cognate kinase EnvZ is used as a resistance strategy by E. coli cells to survive
ammonia-mediated antibiosis. Finally, ammonia was shown to enhance the activity of canonical antibiotics, suggesting that
streptomycetes adopt a low-cost strategy to sensitize competitors for antibiosis from a distance.
Introduction
Volatile compounds (VCs) are small molecules with high
vapor pressure and low molecular weight that easily diffuse
through air, water, or soil [1, 2]. VCs have a broad activity
spectrum, acting as infochemicals, growth-promoting or
inhibiting agents, modulators of quorum sensing and drug
resistance or as a carbon-release valve, influencing their
neighbor’s behavior and phenotypes such as stress
response, colony morphology, biofilm, virulence, and pig-
mentation [3–7]. In soil, VCs play important roles in inter-
and intra-species interactions [8].
Actinobacteria are one of the largest bacterial phyla
present in soil [9, 10]. They are known as Nature’s medicine
makers [11], with the ability to produce bioactive secondary
metabolites that work as antibiotics, anticancer, antifungal,
anthelmintic, and immunosuppressant agents [10, 12, 13].
Streptomycetes alone produce half of all known antibiotics
used in the clinic. They are also prolific producers of VCs,
although their ecological functions remain largely elusive
[14, 15]. In terms of antimicrobial activity of VCs, infor-
mation is primarily available on their activity as antifungals
[9, 16]. A rare example of a VC with antibacterial activity is
the sesquiterpene albaflavenone produced by Streptomyces
albidoflavus [17].
The natural role of antibiotics is subject to intensive
debate. It has been argued that their main function lies in
cell to cell communication [18]. However, antibiotics may
well act as weapons, and bioactivity is influenced by
social and competitive interactions between strains [19].
Interestingly, it is becoming more evident that the small
inorganic VCs such as hydrogen sulfide (H2S) and nitric
oxide (NO) play a major role in modulating antibiotic
activity and resistance [20]. For example, H2S production
protects bacteria against antibiotics targeting DNA, RNA,
protein, and cell wall biosynthesis [21]. Furthermore,
Bacillus anthracis produces NO to protect itself against
oxidative stress and helps the bacterium to survive in
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macrophages, thus playing a key role in escaping the
host’s defense [22, 23]. Production of NO also directly
protects bacteria against a broad spectrum of antibiotics
[24, 25]. Ammonia induced resistance to tetracycline, by
increasing the level of polyamines which leads to a
modification of membrane permeability [26]. There is also
some experimental evidence that suggests that VCs may
affect membrane integrity [27, 28], which in turn may
make the cells more susceptible to other cell-damaging
compounds, such as antibiotics. To date, however, more
conclusive experimental evidence for the ecological roles
of VCs produced by bacteria and for the mechanisms
underlying resistance to VCs is limited.
In this study, we show for the first time that Streptomyces
can produce surprisingly high levels of ammonia that affect
growth of Gram-positive and Gram-negative bacteria over
long distances. We also show that the production of
ammonia in Streptomyces is affected by the growth condi-
tions and that its biosynthesis depends on the glycine
cleavage system. The same is observed in an in vivo assay
where we show that the ammonia-producing wild type S.
griseus inoculated into soil inhibits the growth of B. subtilis
whereas the S. griseus glycine riboswitch-null mutant
(gcvT) did not. Finally, E. coli cells gain resistance against
ammonia by reducing the expression of the two-component
system OmpR-EnvZ, thereby counteracting passage
through the outer membrane porins.
Materials and methods
Strains, media, culture conditions, and antimicrobial
assays
Strains used in this study are listed in Table S1. The
Streptomyces strains were grown on Soy Flour Mannitol
(SFM) agar plates to prepare spore stocks. Escherichia coli
strain AS19-RlmA− [29] and B. subtilis 168 [30] were used
as test microorganisms and grown on Luria-Bertani (LB)
agar plates.
Volatile antimicrobial assays were performed using a
petri dish with two compartments, one filled with SFM
media for Streptomyces growth and the second one with LB
+/− TES buffer 50–100 mM. Streptomyces strains were
streaked on the SFM side and allowed to grow for 5 days
after which, E. coli or B. subtilis were inoculated on the LB
side using a concentration of 104 and 103 cfu/mL
respectively.
Collection and analysis of VCs
VCs produced by Streptomyces monocultures grown on
SFM agar were collected using a glass Petri dish designed
for trapping of the volatile headspace [31]. The lid of the
glass Petri dish contains an outlet specially designed to hold
a stainless-steel column packed with 200 mg Tenax® TA
60/80 material (CAMSCO, Houston, TX, USA). Samples
were taken in triplicates from day 3 to day 5 of growth; after
that, the Tenax steel traps were sealed and stored at 4 °C
until GC-Q-TOF analysis.
Trapped volatiles were desorbed using an automated
thermodesorption unit (model UnityTD-100, Markes
International Ltd., United Kingdom) at 210 °C for 12 min
(Helium flow 50 mL/min) and trapped on a cold trap at
−10 °C. The trapped volatiles were introduced into the
GC-QTOF (model Agilent 7890B GC and the Agilent
7200A QTOF, USA) by heating the cold trap for 3 min to
280 °C. A 30 × 0.25 mm ID RXI-5MS column with a film
thickness of 0.25 μm was used (Restek 13424–6850,
USA). Temperature program used was as follows: 39 °C
for 2 min, from 39 to 95 °C at 3,5 °C/min, then to 165 °C
at 6 °C/min, to 250 °C at 15 °C/min and finally to
300 °C at 40 °C/min, hold 20 min The VCs were detected
by the mass spectrometer (MS) operating at 70 eV in EI
mode. MS spectra were extracted with MassHunter Qua-
litative Analysis Software V B.06.00 Build 6.0.633.0
(Agilent Technologies, USA) using the GC-Q-TOF qua-
litative analysis module. MS spectra were exported as
mzData files for further processing in MZmine. The files
were imported to MZmine V2.14.2 [32] and compounds
were identified via their mass spectra using deconvolution
function (Local-Maximum algorithm) in combination
with two mass-spectral-libraries: NIST 2014 V2.20
(National Institute of Standards and Technology, USA
http://www.nist.gov) and Wiley 9th edition mass spectral
libraries and by their linear retention indexes (LRI). The
LRI values were calculated using an alkane calibration
mix before the measurements in combination with
AMDIS 2.72 (National Institute of Standards and Tech-
nology, USA). The calculated LRI were compared with
those found in the NIST and in the in-house NIOO-
KNAW LRI database. After deconvolution and mass
identification peak lists containing the mass features of
each treatment (MZ-value/Retention time and the peak
intensity) were created and exported as CSV files for
statistical processing via MetaboAnalyst V3.0 (www.meta
boanalyst.ca; [33]).
pH change, ammonia determination, and toxicity
Change in pH of the growth media was determined by the
addition of phenol red indicator (0.002%). Pictures were
taken after 0, 3, and 5 days of incubation next to Strepto-
myces biomass. For the ammonia test, Streptomyces strains
were grown for 5 days on SFM agar using the two-
compartment petri-dish, whereby the other half of the plate
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was left empty. After 5 days, the ammonia was determined
using the Quantofix® ammonium test kit. Pictures were
recorded to obtain a qualitative measurement of ammonia
production from each strain.
Quantification of ammonia accumulation inside the LB
agar was determined by extracting the liquid from the LB
agar by centrifugation. For this, centrifuge tube filters
were used (spin-X® 0.22 μm cellulose acetate, Corning
Inc. USA), 1 cm2 of agar was taken 1 cm away from the
plastic barrier separating the Streptomyces biomass. The
plug was put inside the filter tube and centrifuge at
13,000 rpm for 20 min. The eluate (∼200 μL) was used to
quantify the ammonium concentration in comparison to a
standard curve. The standard curve was made with LB
agar containing 0–50 mM concentrations of ammonia.
Ammonia solution (25% in H2O, J.T. Baker 6051) was
used as source of ammonia. The liquid was extracted from
the agar the same way as described before and used
together with the Quantofix® ammonium kit to obtain a
semi-quantitative measure of ammonia accumulation
inside the agar.
To determine the toxicity of ammonia, E. coli and B.
subtilis were incubated in the automated Bioscreen C (Lab
systems Helsinki, Finland) in the presence of increasing
concentrations of ammonia. Each dilution was prepared in
LB containing an inoculum of 105 cfu/mL+ different
volumes of ammonia solution (J.T. Baker) to give the
following final concentrations: 1, 5, 10, 15, 16, 17, 18, 20,
25, 30, 40, and 50 mM. The final working volume in each
well of the honeycomb was 100 μL. Cultures were incu-
bated at 37 °C overnight with continuous shaking. O.D.
measurements (wideband) were taken every 30 min for
20 h. The data and growth curves were calculated from
triplicates.
Ammonia production in soil
To detect the production of ammonia by Streptomyces
inoculated in field soil, a microrespirometry-like system
[34] was used. The assembled system was comprised of a
96 deep-well plate with a capacity of 2 mL (Favorgen
biotech corp.) interconnected to a top 96 well plate with flat
bottom (Greiner bio-one) via a CapMat of 96 naps (Greiner
bio-one). Holes were made to the CapMat to allow the
passage of volatiles and avoid cross contamination between
wells. On the bottom plate 0.5 g of sterile soil were placed
in each well and 100 μL of trace elements solution were
added (ZnCl2 0.08 mg/mL; FeCl3·6H2O 0.4 mg/mL;
CuCl2·2H2O 0.02 mg/mL; MnCl2·4H2O 0.02 mg/mL;
Na2B4O7·10H2O; (NH4)6Mo7O24·10H2O 0.02 mg/mL). One
hundred microliters of a spore suspension of S. griseus
wild-type or S. griseus gcvT [35] were inoculated in order to
give a final concentration of 1 × 106 spores/well. The final
moisture content was 40% (v/w). In the control treatment,
no Streptomyces was inoculated. For the upper plate, each
well was filled with 130 μL of LB with 0.002% phenol red
as pH indicator. This plate was sealed with the CapMat with
holes and the two 96 well plates were sealed together using
parafilm. The final setup is shown in Fig. 5. The system was
incubated for 10 days at 30 °C. After this, the top plate was
inoculated with 2 μL of a suspension of B. subtilis at an
OD600 of 0.1, sealed with a new CapMat without holes and
incubated at 37 °C. The bottom plate was used to check the
growth of Streptomyces. Growth was determined qualita-
tively by the appearance of Streptomyces colonies on top of
the soil and visualized by stereo microscopy using a Zeiss
Lumar V12 steremicroscope. Streptomyces growth was
determined quantitatively by dilution plating soil suspen-
sions onto SFM.
HCN determination
To detect hydrogen cyanide in the headspace of Strepto-
myces growth we used a method adapted from Castric and
Castric [36]. For this, Whatman™ paper was soaked in
suspension containing 5 mg/ml of copper(II) ethyl acet-
oacetate and 4,4′-methylenebis-(N,N-dimethylaniline)
(Sigma-Aldrich, USA) dissolved in chloroform and allowed
to dry protected from light. The filter paper was placed next
to Streptomyces pre-grown for 2 days. Pseudomonas don-
ghuensis P482 was used as positive control. Strains were
incubated at 30 °C until blue coloration of the filter paper
was evident.
Whole genome sequencing
Genome sequencing of E. coli AS19-RlmA− [37] and its
mutant ARM9 was performed using Illumina HiSEQ and
PacBio RfavaS at Baseclear BV, Leiden (The Netherlands).
Paired-end sequence reads were generated using the Illu-
mina HiSeq 2000 system and mapping the individual reads
against the reference genome of E. coli B str. REL606. The
contigs were placed into superscaffolds based on the
alignment of the PacBio CLC reads. Alignment was per-
formed with BLASR [38]. Genome annotation was per-
formed using the Baseclear annotation pipeline based on the
Prokaryotic Genome Annotation System (http://
vicbioinformatics.com). Variant detection was performed
using the CLC genomics workbench version 6.5. The initial
list of variants was filtered using the Phred quality score and
false positives were reduced by setting the minimum variant
frequency to 70% and the minimum number of reads that
should cover a position was set to 10. Relevant mutations
were confirmed by PCR analysis. The genome of E. coli
AS19-RlmA− has been published, with accession number
CP027430 [37].
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Genetic complementation of ompR and envZ
E. coli strain AS19-RlmA− suppressor mutant ARM9 was
complemented by inserting the ompR or envZ genes in
pCA24N from the ASKA collection [39]. Cells of sup-
pressor mutant ARM9 containing the plasmid were inocu-
lated in LB + Chloramphenicol (25 μg/mL) with or without
IPTG 0.1 mM for induction of the gene expression.
RNA sequencing
For RNA extraction E. coli cells were grown to an O.D.600
of 0.5, RNA Protect Bacteria Reagent (Qiagen Cat No.
76506) was added according to manufacturer instructions.
Cells were pelleted and re-suspended in boiling 2% SDS+
16 mM EDTA followed by extraction with Phenol:chloro-
form:Isoamyl alcohol (25:24:1) pH 6.6. (VWR Prolabo
436734C). Aqueous phase was precipitated with 3M
sodium acetate pH 5.2 and pure ethanol, washed with 70%
Ethanol and re-suspended in RNAse-free water. DNA was
removed using five units of DNAseI (Fermentas #EN0521)
with further purification using again phenol:chloroform:
isoamyl alcohol and precipitation with sodium acetate and
ethanol. The final pellet was dissolved in RNase free water.
RNA sequencing and analysis was performed by Base-
clear BV (Leiden, The Netherlands). Ribosomal RNA was
subsequently removed with a Ribo-Zero kit (Epicenter) and
the remaining RNA used as input for the Illumina TruSeq
RNA-seq library preparation. Once fragmented and con-
verted into double strand cDNA, the fragments (about
100–200 bp) were ligated with DNA adapters at both ends
and amplified via PCR. The resulting library was then
sequenced using an Illumina Sequencer. The FASTQ
sequence reads were generated using the Illumina Casava
pipeline version 1.8.3. Initial quality assessment was based
on data passing the Illumina Chastity filtering. Subse-
quently, reads containing adapters and/or PhiX control
signals were removed using an in-house filtering protocol.
The second quality assessment was based on the remaining
reads using the FASTQC quality control tool version
0.10.0.
For the RNA-Seq analysis the quality of the FASTQ
sequences was enhanced by trimming off low-quality bases
using the “Trim sequences” option present in CLC Geno-
mics Workbench Version 6.0.4 (QIAGEN, Bioinformatics).
The quality-filtered sequence reads were used for further
analysis with CLC Genomics Workbench. First an align-
ment against the reference and calculation of the transcript
levels was performed using the “RNA-Seq” option. Sub-
sequent comparison of transcript levels between strains and
statistical analysis was done with the “Expression analysis”
option, calculating so-called RPKM values. These are
defined as the reads per kilobase per million mapped reads
[40] and normalizes for the difference in the number of
mapped reads between samples and for transcript length.
The RNAseq data has been submitted to the Gene
Expression Omnibus (GEO) from National Biotechnology
Center Information (NCBI) with GEO accession number
GSE111370.
Synergism of Streptomyces AB-VCs with soluble
antibiotics
Synergistic assays were performed using a petri dish with
two compartments, one filled with SFM media for Strep-
tomyces growth and the second one with LB. Streptomyces
strains were streaked on the SFM side and allowed to grow
for 5 days at 30 °C after which, E. coli or B. subtilis were
inoculated on the LB side using a culture grown to an
O.D.= 0.5. One hundred microliters were streaked on the
LB side. Afterwards, 6 mm filter disks (Whatman™) were
placed on top of the LB and 10 μL of each antibiotic spotted
on the filter disc. Two different concentrations per antibiotic
were tested: ampicillin 500, 31 μg/mL; erythromycin
250, 31 μg/mL; kanamycin 1000, 500 μg/mL; tylosin 500,
62 μg/mL; actinomycin 500, 62 μg/mL; spectinomycin
1000, 500 μg/mL; streptomycin 500, 62 μg/mL. Plates were
incubated at 37 °C overnight and pictures recorded after
20 h of growth.
Results and discussion
VCs as bioactive agents in long-distance antibiosis
To investigate if streptomycetes produce antibacterial VCs,
different Streptomyces strains were grown physically sepa-
rated from indicator/target bacteria by a polystyrene barrier.
Air-borne VCs can pass over the barrier, but it does not
allow passage of canonical (soluble) antibiotics. We used
Bacillus subtilis and Escherichia coli strain AS19-RlmA−
(referred to as E. coli ASD19 from now on) as Gram-
positive and Gram-negative indicator strains, respectively.
The latter has known antibiotic sensitivity [29]. Interest-
ingly, the streptomycetes showed varying volatile activity
against E. coli ASD19; this strain failed to grow adjacent to
Streptomyces sp. MBT11 or S. venezuelae, but grew nor-
mally next to S. coelicolor, S. lividans, and S. griseus
(Fig. 1a). B. subtilis was not inhibited by any of the
Streptomyces strains tested.
We then wanted to assess whether the production of
antimicrobial volatile compounds (AMVCs) could be eli-
cited by varying the growth conditions. We previously
showed that growth at pH 10, N-acetylglucosamine, starch
or yeast extract pleiotropically enhanced the production of
antibiotics in many Streptomyces species [41]. Interestingly,
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in contrast to a neutral pH, when glycine/NaOH buffer
(25 mM glycine) [42] was added to raise the pH to 10, S.
griseus produced VCs that completely inhibited growth of
E. coli and B. subtilis (Fig. 1b). The production of AMVCs
by Streptomyces sp. MBT11 was also enhanced by growth
in the presence of the buffer system (data not shown). In
contrast, S. coelicolor failed to produce AMVCs under any
of the conditions tested (Table S2). Intriguingly, when
grown on 0.8% peptone, S. lividans was able to inhibit B.
subtilis but not E. coli. Comparative GC-profiling with S.
lividans grown in media with different concentrations of
peptone followed by compound identification and bioac-
tivity assays will be needed to establish which volatile
compound(s) cause(s) this effect.
The induction of AMVCs by S. griseus when grown on
the glycine buffer offered an ideal system to elucidate the
nature of the bioactive molecules by statistical methods.
Correlation between bioactivity and metabolic
profiles allows efficient reduction of candidate molecules
[43, 44]. Therefore, GC-Q-TOF-based metabolomics was
performed to compare the VC profiles of S. coelicolor,
Streptomyces sp. MBT11, S. venezuelae and S. griseus (the
latter grown with and without glycine buffer pH 10).
Despite the antimicrobial activity, no volatile organic
compound (VOC) was detected that correlated statistically
to the bioactivity, nor did we see any significant difference
between the metabolome profiles of S. griseus grown with
or without the glycine buffer (Fig. 1c, d). Some of the mass
features suggested differential production of 2-
methylisoborneol (2-MIB) and 2-methylenebornane by the
active strains compared to the non-active strains. However,
mutants of S. griseus that lacked either or even all the ter-
pene cyclases, still retained their antibacterial volatile
activity (data not shown).
The main inhibitory molecule is ammonia
VCs may induce a change in pH away from the producing
colonies [45, 46]. To assess this, we used phenol red, which
changes from pale orange to bright pink when the media
becomes more alkaline. Interestingly, a gradual increase
was seen in the pH caused by VCs produced by
Fig. 1 Bioactivity and metabolomic analysis of VCs released by
streptomycetes. a Bioactivity of VCs released by selected Strepto-
myces strains against E. coli strain ASD19. b Volatile antibiotic
activity of different Streptomyces strains grown at pH 7 or pH10, the
latter by addition of a glycine/NaOH buffer; E. coli strain ASD19 was
the indicator strain. c Comparison of GC-chromatogram of VCs from
bioactive and non-bioactive strains. d PCA-2D Plot showing the VC-
grouping of the different strains. No clear separation between VCs
produced by different Streptomyces strains is seen
Production of ammonia as a low-cost and long-distance antibiotic strategy by Streptomyces species 573
S. venezuelae or by Streptomyces sp. MBT11 that produce
AMVCs, but not by S. coelicolor that lacks the production
of AMVCs in our assays. Initially, a pH increase was seen
close to the Streptomyces biomass, and after 5 days the
receiver side had turned completely pink (Fig. 2a). At that
point, the pH in the medium on the receiver side had
increased to around 8.5. This pH increase correlated with
growth inhibition of E. coli close to the Streptomyces after
3 days, while after 5 days the growth of E. coli was fully
inhibited (Fig. 2b).
Further in support of pH-dependent growth inhibition,
E. coli grew normally when the media was buffered with 50
mM TES (pH 7; data not shown). However, the pH itself
was not the cause of the inhibition, since the E. coli cells
grew normal on media adjusted to pH 9 (Fig. 2c). We also
previously showed that antibiotic susceptibility of E. coli
was similar for pH 10 and pH 7 [41].
Ammonia and trimethylamine (TMA) are VCs known to
induce a pH change [26, 45–47]. We also tested production
of hydrogen cyanide (HCN), a known AMVC produced by
rhizospheric streptomycetes [48]; however, none of the
Streptomyces strains produced detectable amounts of HCN
(Fig. S1). Furthermore, under our growth conditions, TMA
was not detected in the headspace of any of the Strepto-
myces strains tested, when grown at pH 7 or pH 10.
(Fig. S2). Following ammonia detection using the Quan-
tofix® Ammonium detection kit, we found that antibiosis by
the streptomycetes strongly correlated with an increase in
ammonia production (Fig. 2d). To determine the ammonia
concentrations in vitro, the Streptomyces strains were grown
for 5 days and the agar on the receiver side extracted. Agar
containing different concentrations of ammonia was used to
create a standard curve. S. coelicolor, S. lividans, and S.
griseus (pH 7) accumulated 2–5 mM ammonia, while the
growth-inhibiting S. venezuelae, Streptomyces sp. MBT11,
Streptomyces sp. MBT21 as well as S. griseus—the latter
only with added Gly/NaOH buffer pH 10—produced
15–30 mM ammonia (Fig. 3a). Subsequent assays showed
that E. coli failed to grow on media with 20 mM ammonia
or higher, while growth of B. subtilis was inhibited by
ammonia concentrations above 30 mM (Fig. 3b). These
values are within the range produced by the strains causing
volatile-mediated antibiosis, strongly suggesting that
ammonia is indeed the AMVC produced by the antagonistic
Streptomyces strains.
Ammonia is derived from glycine cleavage
We then wondered if ammonia was generated from glycine
metabolism, because a glycine/NaOH buffer was used to set
the pH. A major pathway for the catabolism of glycine is
the glycine cleavage system (GCV) that converts glycine
into CO2, ammonia and a methylene group that is trans-
ferred to tetrahydrofolate (THF) to form N5, N10-methylene-
THF [35, 49]. Importantly, when S. griseus was grown on
SFM agar containing glycine only at concentrations as low
Fig. 2 pH increase is caused by high ammonia production. a pH
change illustrated by the color change of the indicator (Phenol red
0.002%). LB medium alkalization after 3 and 5 days of growth of
Streptomyces sp. MBT11 and S. venezuelae, no alkalization was
caused by VCs produced by S. coelicolor. b Streptomyces sp. MBT11
antimicrobial VCs production curve against E. coli strain ASD19. c E.
coli strain ASD19 and B. subtilis growth under different pH adjusted
with glycine/NaOH buffer. d NH3 emission. Test strips on the right
compartment show the production of NH3 by Streptomyces strains.
S. coelicolor and S. lividans (∼10 mg/L); S. venezuelae (∼100 mg/L);
Streptomyces sp. MBT11, and Streptomyces sp. MBT21 (∼100 mg/L);
Control: SFM media (0 mg/L). Concentrations are estimated according
to the color chart indicator from the Quantofix® ammonium
detection Kit
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as 0.1% (w/v), this time without increasing the pH, the
strain still fully inhibited the growth of B. subtilis and E.
coli (Fig. 4a). We then also grew S. coelicolor on SFM agar
with increasing concentrations of glycine. Interestingly, at
concentrations of 1% (w/v) glycine or higher, also S. coe-
licolor fully inhibited the indicator/target cells. This
Fig. 4 Bioactivity is caused by ammonia in a glycine cleavage-
dependent manner. a Volatile activity and ammonia production by S.
griseus, S. griseus glycine cleavage mutant gcvP (ΔUTR-P), S. griseus
glycine cleavage mutant gcvT (ΔUTR-T), S. griseus glycine cleavage
double mutant gcvT-gcvP (ΔUTR-T/ΔUTR-P), S. coelicolor, and the
S. coelicolor glycine cleavage system mutant ΔgcvP. b Scheme
representation of the reactions carried by the glycine cleavage (GCV)
system, consisting of pyridoxal phosphate-containing glycine dec-
arboxylase GcvP (blue); THF-dependent aminomethyltransferase
GcvT (yellow); dihydrolipoamide dehydrogenase GcvL; and lipoic
acid-containing carrier protein GcvH. c Illustration of the induction of
volatile antibiosis in different Streptomyces strains when increasing
concentrations of glycine are added
Fig. 3 Bioactivity is caused by
ammonia. a Ammonia
quantification from LB agar
extracts exposed to
Streptomyces VCs (left).
Ammonia standard curve from
LB agar extract (right).
b Growth of E. coli ASD19
(black) and B. subtilis (gray)
under different concentrations of
ammonia
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suggests that at sufficiently high concentrations of glycine,
all streptomycetes tested can produce ammonia to a level
that inhibits the growth of other bacteria.
To investigate the involvement of the GCV system [35],
we tested mutants deficient in the glycine cleavage system
which consists of three enzymes (GcvL, GcvP, GcvT) and a
carrier protein: GcvH (Fig. 4b). The gcvP and gcvT mutants
of S. griseus have deletions in the 5′ UTR, and therefore
lack a glycine riboswitch that controls the expression of
the genes. Conversely, the gcvP mutant in S. coelicolor has
the entire gcvP replaced by an apramycin resistance cas-
sette. The gcvP mutant of S. coelicolor [50] and the gcvT
mutant of S. griseus [35] were unable to produce inhibiting
amounts of ammonia, even when grown on high amounts of
glycine. A mutant of S. griseus lacking the 5′UTR of gcvP
[35] still produced sufficient ammonia to inhibit the growth
of E. coli cells, but this was annihilated by the additional
deletion of gcvT (Fig. 4a). Taken together, this strongly
suggests that in both S. coelicolor and S. griseus, volatile
ammonia is primarily derived from the GCV system, and—
as expected—that GcvT is the key enzyme responsible for
the production of ammonia from glycine. Inactivation of
gcvP is also sufficient to block volatile ammonia production
in S. coelicolor, which is in line with the idea that the key
system is GCV. The silencing rather than deleting the gcv
genes in S. griseus, may allow some residual expression of
the genes, and this could explain why the S. griseus gcv
mutants still produce sufficient amounts of ammonia to
exert antibacterial activity.
A major difference between S. coelicolor and S. griseus
on the one hand, and S. venezuelae and Streptomyces sp.
MBT11 on the other, is that the latter two strains do not
require any added glycine to produce levels of ammonia
above the minimal inhibitory concentration (MIC). In this
case, ammonia may be derived from the catabolism of other
amino acids or from other metabolic enzymes, such as
ammonia lyases, deaminases, deiminases, and pyridox-
amine phosphate oxidases. We now aim to identify the gene
(s) and pathways responsible for the overproduction of
ammonia in these strains.
Ammonia production in situ
In order to investigate if volatile-mediated antagonism from
a distance could also occur in a more ecologically relevant
environment, we introduced S. griseus and the gcvT mutant
in soil and assessed the antibacterial activity of the volatiles
emitted from the soil in the headspace both in absence and
with increasing concentrations of glycine. The production
of ammonia was detected using LB with phenol red as pH
indicator in a 96 well plate assembled on top of the deep
wells with soil inoculated with the Streptomyces strain or
mutant.
S. griseus and the gcvT mutant were both able to grow in
soil, with and without added glycine. When glycine was
added, the growth of S. griseus was boosted indicating that
it was able to metabolize the amino acid, whereby 0.1% of
glycine was optimal for growth. S. griseus gcvT mutant is
unable to metabolize glycine, and expectedly, its growth
was not enhanced by glycine; as a result, growth of the gcvT
mutant was slightly lower in soil containing glycine than
that of the wild type strain, but enough to be comparable
(Figs. 5 and S3). Ammonia was produced by S. griseus but
not by the gcvT mutant as observed by the change of phenol
red from yellow to pink in the top indicator plate. A gradual
change in color was observed, which was proportional to
the glycine concentration. When B. subtilis was spotted
inside the top wells, it grew well when exposed to the VCs
from the gcvT mutant, while strong growth inhibition was
observed when spotted in the wells exposed to the VCs
from wild-type S. griseus (Fig. 5 right). The antagonistic
effect correlated with the ammonia levels released into the
headspace and with an increasing amount of glycine added
to the soil. These data show that long-distance killing by
ammonia produced by streptomycetes also occurs in a soil
environment, provided that glycine is available. Glycine is
an abundant amino acid found in root exudates [51, 52]
making its presence in soil feasible. Furthermore, microbial
interactions in soil and rhizosphere environments typically
occur in microsites where sufficiently high substrate (i.e.,
glycine) concentrations can be reached to allow for VC-
mediated antibiosis.
OmpR is key to ammonia resistance
To obtain more insights into the resistance mechanisms to
ammonia-mediated antibiosis, we selected for spontaneous
ammonia-resistant mutants in E. coli cells exposed to
ammonia produced by Streptomyces sp. MBT11. After two
days of growth, several E. coli colonies appeared that were
able to withstand the accumulated ammonia and likely had
sustained one or more suppressor mutations. Four of these
colonies were analyzed further, which showed different
levels of resistance based on the colony size (Fig. S4A). Of
these, suppressor mutant ARM9 was selected for its high
resistance (Fig. 6a left). Strain ARM9 was reproducibly
more resistant to ammonia than its parent, with MICs of 25
and 20 mM, respectively. This is a biologically significant
difference, as we previously showed that 20 mM is pre-
cisely the tipping point for ammonia sensitivity of E. coli
(Fig. 6b).
Under low availability of nitrogen, the AmtB transporter
facilitates the intake of ammonium inside the cell [53, 54].
Our conditions include high concentrations of ammonia;
therefore, we hypothesized that a mechanism other than the
AmtB channel would be involved in the resistance towards
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ammonia. To identify the nature of the mutation(s) sus-
tained by ARM9, its genome sequence was compared to
that of its parent E. coli ASD19 (Table S3). In total 658
mutations were found by single nucleotide permutation
analysis, of which 198 gave rise to amino acid changes or
insertions or deletions. However, one change immediately
stood out, namely the introduction of two insertion elements
(insA_31 and insB_31) in-between the −35 and −10 con-
sensus sequences of the promoter for ompR-envZ, which
encode the two-component system (TCS) consisting of
response regulator OmpR and sensory kinase EnvZ (Fig. 6a
right). This TCS is involved in osmoregulation in response
to environmental signals [55] and regulates the expression
of outer membrane porins OmpF and OmpC. Importantly,
these are known to be involved in antibiotic resistance
regulated by osmotic pressure and pH [56], and to reduce
the responsiveness of E. coli cells to VCs [5].
Reduced transcription of the ompR-envZ operon is
the cause of ammonia resistance
Considering the location right in the middle of the promoter,
we expected that the IS elements in the ompR-envZ pro-
moter reduced the transcription of these crucial TCS genes.
To establish the transcriptional consequences of the IS
insertion into the ompR-envZ promoter region, RNAseq was
Fig. 5 Long-distance inhibition of B. subtilis by volatile ammonia
produced by S. griseus in soil. Experiments were done with a wild
type S. griseus, and b S. griseus ΔgcvT that lacks the glycine cleavage
system. In each panel, the bottom left image shows the growth of
Streptomyces in 96 well plates filled with soil with the ammonia
detection plate placed on top, and top left stereo micrographs of
Streptomyces colonies growing on top of the soil. The top right side
shows the color change of phenol red if ammonia is produced and the
corresponding B. subtilis inhibition or growth. The graphs on the
bottom right side shows the quantitative measurement of the OD600 of
each well where B. subtilis was spotted. *indicates statistical sig-
nificance. Note that growth of B. subtilis was inhibited significantly by
wild-type S. griseus but not by its gcvT null mutant
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performed on E. coli ASD19 and its suppressor mutant
ARM9 grown in LB media until mid-exponential phase
(OD600 0.5), and the global transcription profiles compared
(see Table S4 for the full dataset). Table 1 shows genes
highly up/down regulated as a result of a clustering analysis
using a cutoff value of a fold change ±2.0. These data
confirm the downregulation of ompR and envZ genes and
other related genetic elements like omrA, a small noncoding
RNA that negatively regulates ompR expression. Addi-
tionally, genes involved in amino-acid metabolism were
down regulated, including the astABCE gene cluster
involved in the ammonia-producing arginine catabolic
pathway, aspA that is involved in the conversion of L-
aspartate into fumarate and ammonia, and tnaC for cata-
bolism of tryptophan, which again releases ammonia.
To confirm that indeed the reduced transcription of
ompR-envZ was the major cause for the acquired ammonia
resistance, E. coli mutant ARM9 was genetically com-
plemented by the introduction of constructs from the ASKA
collection [39] expressing either ompR or envZ. Introduc-
tion of constructs expressing either ompR or envZ restored
ammonia sensitivity, while transformants harboring the
empty plasmid continued to be resistant (Fig. 6c). This
strongly suggests that the reduced expression of ompR and
envZ was the sole cause of the acquired ammonia resistance.
It is important to note that mutant ARM9 had also become
resistant to AMVCs produced by S. venezuelae and by
S. griseus (the latter grown on glycine), again providing
evidence that all strains act by producing ammonia as the
AMVC (Fig. S4B).
Taken together, these data show that E. coli responds to
exposure to ammonia by reducing ompR-envZ transcription,
down regulating the expression of OMPs to minimize the
passage of small molecules, and by the reduction of
ammonia biosynthesis. Both responses are aimed at defense
against the accumulation of toxic levels of ammonia. When
exposed to ammonia, E. coli ompR mutants were shown to
be significantly more sensitive to tetracycline than the par-
ental strain [26]. Our results show that reducing the
expression of OMPs is a defense mechanism against
ammonia toxicity extending also earlier observations that
ompF mutants show impaired response to VOCs that affect
the motility of E. coli [5].
Ammonia released by Streptomyces modifies
sensitivity to canonical antibiotics
Since ammonia is an AMVC that can reach far from the
colony, we hypothesized that the molecule may play a role
in long-distance competition with other microbes in the soil,
Fig. 6 Insertion sequences in the E. coli ompR-envZ promoter govern
resistance to ammonia. a (left) spontaneous suppressor mutant ARM9
derived from E. coli strain ASD19 growing under the presence of
volatile compounds produced by Streptomyces sp. MBT11; (right)
visualization of insertion sequences in-between the −10 and
−35 sequences of the ompR/envZ promoter. b Growth of E. coli strain
ASD19 (black) and E. coli strain ASD19 suppressor mutant ARM9
(gray) under the presence of different concentrations of ammonia.
c Growth of suppressor mutant ARM9 and transformants harboring
either empty plasmid pCA24N, plasmid ompR-pCA24N (expressing
ompR), or plasmid envZ-pCA24N (expressing envZ). Note that intro-
duction of a plasmid expressing either envZ or ompR makes
ARM9 sensitive again to ammonia
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Table 1 Clustering of the differentially down/upregulated genes in ARM9 compared with ASD19. Only fold changes >2.0 or ≤2.0 are shown




envZ Sensory histidine kinase in two-component regulatory
system with OmpR
−16.43
omrA Small regulatory RNA −15.86
yhdV Putative outer membrane protein −15.86
ompR Response regulator in two-component regulatory system
with EnvZ
−14.84
dacD D-alanyl-D-alanine carboxypeptidase, penicillin-binding
protein 6b
−6.47
yqhH Outer membrane lipoprotein, Lpp paralog −6.20
ydiM Putative MFS transporter, membrane protein −4.83
yiaD Multicopy suppressor of BamB, outer membrane
lipoprotein
−4.54
yajR Putative transporter −4.37
yhfL Small lipoprotein −3.22
Domain: EAL bluF Anti-repressor for YcgE, blue light-responsive, FAD-
binding, inactive c-di-GMP phosphodiesterase-like EAL
domain protein
−2.55
yhjH Cyclic-di-GMP phosphodiesterase, FlhDC-regulated −2.13
ycgG Putative membrane-anchored cyclic-di-GMP
phosphodiesterase
−2.36
























astA Arginine succinyltransferase −2.17
astB Succinylarginine dihydrolase −2.09
astC Succinylornithine transaminase, PLP-dependent −2.13
astE Succinylglutamate desuccinylase −2.14
feaR Transcriptional activator for tynA and feaB −2.02
tnaC Tryptophanase leader peptide −2.21
Fatty acid oxidation fadA 3-ketoacyl-CoA thiolase (thiolase I) −2.20
fadB Fatty acid oxidation complex, α component −2.19
fadH 2,4-dienoyl-CoA reductase, NADH and FMN-linked −2.14
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e.g., by modifying the effect of other antibiotics produced
by actinomycetes, such as erythromycin, kanamycin, acti-
nomycin, spectinomycin, and streptomycin. This could be
an interesting synergistic effect whereby weapons produced
by the strain itself are potentiated via ammonia. To have an
indication, the streptomycetes were grown on the left side of
the agar plates for 4 days to allow accumulation of com-
pounds on the receiver side containing LB. After that, B.
subtilis and E. coli BREL606 (more resistant to AMVCs)
were plated next to Streptomyces strains and a filter disk
placed on the agar containing different canonical antibiotics.
Interestingly, we noticed a significant increase in the sen-
sitivity of B. subtilis and E. coli to most antibiotics when
ammonia-producing streptomycetes were grown adjacent to
the receiver cells (Fig. 7). Thus, bioactive VCs from
Streptomyces modulate the activity of soluble antibiotics at
longer distances, thereby allowing them to exploit anti-
biotics produced by other bacteria, or to enhance the activity
of its own antibiotics. This novel concept should be worked
out further to consider antibiotic-related susceptibility/
resistance but also tested in ecological settings in situ, such
as competition experiments in controlled microcosms with
microbial consortia.
Implications on ecology and antibiotic activity
Streptomyces VCs have a perceivable impact on the pH of
their surroundings. Research has shown that richness and
diversity of bacterial soil microbiomes is largely explained
by the soil pH [57] with acidic soils having the lowest
diversity. Basic environments favor bacterial growth while
acidic environments do it for fungi [58, 59]. Studies have
shown that VCs are more strongly adsorbed in alkaline
soils, especially those containing high organic carbon con-
tent (2.9%) [60]. High concentrations of ammonia are
achieved in densely populated environments, like the
human intestine where ammonia concentrations range from
12 to 30 mM [61]. Besides, its volatile characteristic allows
Fig. 7 Cooperativity between VCs and soluble antibiotics produced by
streptomycetes. Left: changes in antibiotic sensitivity caused by the
presence of Streptomyces VCs. values indicated increase (+) in halo
size. NC, no changes; NA, not active. Right: representative images
showing changes in halo size. Streptomycetes were grown on SFM
agar, allowed to growth for 4 days, prior to streaking of the indicator
strains. Filter disks containing the antibiotic were placed immediately
after plating the indicator strains
Table 1 (continued)
Cluster Gene Function Fold change
prpB 2-methylisocitrate lyase −2.07
Upregulated
Prophage xisD Pseudogene, exisionase in defective prophage DLP12 7.252
ylcI DUF3950 family protein, DLP12 prophage 5.318
Ribosome rrsC 16S ribosomal RNA 3.93





Pilus fimC Periplasmic chaperone 2.42
fimF Minor component of type 1 fimbriae 2.05
ppdD Putative prepilin peptidase-dependent pilin 4.35
ydeR Putative fimbrial-like adhesin protein 2.18
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ammonia to travel far from the producer, enabling it to
mediate long-distance interactions. To the best of our
knowledge, this is the first report showing that abundant soil
bacteria such as Streptomyces actively kill other bacteria
through the air, via the production of ammonia. Additional
ecological impact is provided by work of others that have
shown that ammonia is a trait that correlates positively and
significantly to some plant characteristics such as elongation
of roots and shoots [62]. For some plants like A. thaliana,
however, exposure to biogenic ammonia produced by Ser-
ratia odorifera reduced its growth [63]. With the knowl-
edge we obtained in our controlled experiments, we now
have generated tools (e.g., mutants) to begin to address the
ecological importance of ammonia and other volatiles pro-
duced by streptomycetes in situ. In this context, our results
suggest that the release of ammonia could help the solubi-
lity and diffusion of other types of secondary metabolites,
while sensitizing competing bacteria. Therefore, the pro-
duction of a small low-cost ammonia is also a logical
strategy for bacteria to enhance the activity of more com-
plex and costly antibiotics, such as polyketides, non-
ribosomal peptides or β-lactams. After all, synthesis of
these compounds requires expensive high-energy precursors
like ATP, NADPH and acyl-CoAs. This is applicable both
to antibiotics produced by the organism itself, and to those
produced by bacteria further away from the colony. The
validity of this concept of “antibiotic piracy” requires fur-
ther experimental testing.
In conclusion, our work shows that several streptomy-
cetes can use ammonia as a low-cost airborne weapon to
change their surrounding environment, thereby making their
own, more costly defense mechanisms more effective. In
this microbial warfare, the surrounding bacteria then
respond by reducing the permeability of their outer mem-
brane and by switching off ammonia production. The field
of AMVCs should continue to be studied as it may offer
new opportunities for agricultural and/or medical applica-
tions, such as for crop protection and natural product
discovery.
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